PHILADELPHIA — (Oct. 8, 2024) — New research from The Wistar Institute’s Salvino lab — led by professor Joseph Salvino, Ph.D. — has identified a novel series of SARS-CoV-2 Mpro inhibitors that may …
PHILADELPHIA — (September 17th, 2024) — The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in Parkinson’s disease…
PHILADELPHIA, PA – August 13, 2024 – The Wistar Institute and Wexford Science & Technology, LLC announced that Wistar has signed a lease for new laboratory and office space at uCity Square in Phila…
PHILADELPHIA — (July 25, 2024) — The Wistar Institute honors 2023 Nobel Prize laureate in Physiology or Medicine Katalin Karikó, Ph.D., as the 2024 Helen Dean King Award recipient. Dr. Karikó, prof…
PHILADELPHIA — (July 16, 2024) —The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute — is creating a new …
PHILADELPHIA — (July 10th, 2024) —On Tuesday, July 16th at 6:30 pm EDT, Nobel Laureate in Medicine or Physiology Drew Weissman, M.D., Ph.D., — Roberts Family Professor in Vaccine Research, Director…
